• Search
  • Advanced Search

Editorial

March 31, 2024


JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary
Cheol Kwak
J Urol Oncol. 2024;22(1):1-3.

Invited Review

March 31, 2024


Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Chang Wook Jeong
J Urol Oncol. 2024;22(1):4-10.

Prostate cancer (PCa) is the second most common cancer globally. However, significant disparities in incidence and mortality exist between countries, especially between Western and Asian regions. This review discusses the...

Invited Review

March 31, 2024


Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
Minseok Suh, Gi Jeong Cheon
J Urol Oncol. 2024;22(1):11-20.

In managing prostate cancer, the integration of multidisciplinary team (MDT) with prostate-specific membrane antigen (PSMA) theranostics marks a significant advancement, addressing the disease's spectrum from indolent forms to aggressive metastatic...

Original Article

March 31, 2024


High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study
Seung-Kwon Choi, Myong Kim, Sang Mi Lee, et al.
J Urol Oncol. 2024;22(1):21-28.

Purpose: To find out the incidence and predictors for late high-grade genitourinary (GU) toxicity following salvage radiotherapy (SRT), we investigated the consecutive patients who were treated with SRT after radical...

Original Article

March 31, 2024


Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study
Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, et al.
J Urol Oncol. 2024;22(1):29-33.

Purpose: To assess the feasibility and short-term efficacy of maintenance enzalutamide following first-line docetaxel plus androgen deprivation therapy (ADT) in patients with high-volume, metastatic castration-naive prostate cancer (mCNPC). Materials and Methods:...

Systemic Review and Meta-analysis

March 31, 2024


Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
J Urol Oncol. 2024;22(1):34-41.

Purpose: The aim of this study was to assess the effects of tyrosine kinase inhibitors (TKIs) following metastasectomy in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods: A systematic...

Original Article

March 31, 2024


Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Jung Hoon Kim, Ji Woong Hwang
J Urol Oncol. 2024;22(1):42-51.

Purpose: Renal cell carcinoma (RCC) is a relatively common malignancy of the urinary tract. Over the past few decades, methodologies for diagnosing and managing patients with RCC have shown various...

Original Article

March 31, 2024


Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center
Hyun Young Lee, Yunjoong Kim, Bumjin Lim, et al.
J Urol Oncol. 2024;22(1):52-58.

Purpose: This study investigated the prognostic factors and cancer-specific survival (CSS) of patients who had renal cell carcinoma (RCC) with venous thrombus and underwent radical nephrectomy with thrombectomy (RNTx). Materials and...

Original Article

March 31, 2024


Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
Joohyun Hong, Ghee Young Kwon, Minyong Kang, et al.
J Urol Oncol. 2024;22(1):59-67.

Purpose: TFE3-rearranged/TFEB-altered renal cell carcinoma (RCC) is a rare subtype of RCC. Due to its rarity, there is an unmet medical need for effective therapies in advanced settings. The study...

Invited Review

March 31, 2024


Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
Sung Han Kim, Ilma S. Savul, Seth P. Lerner
J Urol Oncol. 2024;22(1):68-77.
Radical nephroureterectomy (RNU) remains the gold standard for the surgical management of upper tract urothelial carcinoma (UTUC) from the ureterovesical junction to the renal pelvis. However, the removal of the...

Systemic Review and Meta-analysis

March 31, 2024


Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Purpose: Diabetes mellitus, a frequent comorbid condition in cancer patients, has been shown to increase risk of all-site cancer mortality. This relationship has not been systematically studied in bladder cancer...

Erratum

March 31, 2024


Declaration of Conflict of Interest for Editorial Board Members’ Articles
J Urol Oncol. 2024;22(1):95-96.
Current Issue
Volume 22(1); Mar 2024
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer  (4,138 times)
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol. 2022;20(1):12-24.

Review Article

Feb 24, 2022
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer  (3,836 times)
Jae Young Joung, Sung Han Kim
Korean J Urol Oncol. 2022;20(1):1-11.

Review Article

Feb 24, 2022
The Present and Future of Intravesical Therapy in Bladder Cancer  (3,470 times)
Sin-Woo Seong, Youngjae Shin, In Ho Chang, et al.
Korean J Urol Oncol. 2022;20(2):82-91.

Review Article

May 26, 2022
Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study  (3,029 times)
Minsu Choi, Teak Jun Shin, Byung Hoon Kim, et al.
Korean J Urol Oncol. 2022;20(2):115-122.

Original Article

May 26, 2022
Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?  (2,879 times)
Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo
Korean J Urol Oncol. 2022;20(3):139-150.

Review Article

Aug 25, 2022
Complex Epidemiology of Prostate Cancer in Asian Countries  (2,765 times)
Kagenori Ito, Takahiro Kimura
J Urol Oncol. 2023;21(1):5-13.

Reivew Article

Mar 31, 2023
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer  (2,736 times)
Jeong Hee Hong
Korean J Urol Oncol. 2022;20(4):207-222.

Review Article

Nov 30, 2022
2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS)  (2,709 times)
Chan Ho Lee, Minyong Kang, Cheol Kwak, et al.
Korean J Urol Oncol. 2022;20(3):151-162.

Review Article

Aug 25, 2022
Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer  (2,641 times)
Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):52-58.Correction in: J Urol Oncol 2023;21(3):277

Original Article

Feb 24, 2022
Clinical Utility of Combining Prostate Health Index and PI-RADS Version 2 to Improve Detection of Clinically Significant Prostate Cancer  (2,554 times)
Wan Song, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(2):107-114.

Original Article

May 26, 2022
Artificial Intelligence on Urology Lab  (2,538 times)
Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, et al.
Korean J Urol Oncol. 2022;20(3):163-176.

Review Article

Aug 25, 2022
Enhanced Recovery After Surgery Program for Radical Cystectomy  (2,524 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):92-106.

Review Article

May 26, 2022
Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer  (2,510 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):71-81.

Review Article

May 26, 2022
The Incidence of Prostate-Specific Antigen Test in a Country With a Limited Social Perception of Prostate Cancer 2006-2016: Disparities Manifested by Residential Area  (2,503 times)
Young Hwii Ko, Byung Hoon Kim
Korean J Urol Oncol. 2022;20(1):43-51.

Original Article

Feb 24, 2022
Comparison of Perioperative and Oncologic Outcome Between Old Versus Oldest Old After Radical Cystectomy for Bladder Cancer  (2,436 times)
Sang Soo Park, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(3):186-196.

Original Article

Aug 25, 2022
A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association  (2,382 times)
Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
Korean J Urol Oncol. 2022;20(4):265-272.

Original Article

Nov 30, 2022
Prostate-Specific Antigen Variation as a Predictor of Prostate Cancer in Patients With Prostate-Specific Antigen ≤20 ng/mL Who Underwent Magnetic Resonance Imaging-Targeted Prostate Biopsy  (2,381 times)
Tae Hyun Hwang, Kwang Suk Lee, Kyo Chul Koo, et al.
Korean J Urol Oncol. 2022;20(2):123-132.

Original Article

May 26, 2022
De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors  (2,168 times)
Sung Han Kim, Eun Young Park, Hyung-Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):25-33.

Original Article

Feb 24, 2022
Current Update on Prostate Cancer Immunotherapy  (2,118 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
J Urol Oncol. 2023;21(1):14-22.

Reivew Article

Mar 31, 2023
Solitary Brain Metastasis Detected 1 Year After Robot-Assisted Laparoscopic Radical Nephrectomy: A Case Report  (2,088 times)
Ji Kang Yun, Woong Bin Kim, Si Hyun Kim, et al.
Korean J Urol Oncol. 2022;20(1):63-68.

Case Report

Feb 24, 2022
Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma  (2,064 times)
Jeong Yoon Suh, Se Jung Maeng, Mirinae Kim, et al.
Korean J Urol Oncol. 2022;20(4):223-234.

Review Article

Nov 30, 2022
Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a Young Patient With Gross Hematuria: A Case Report  (2,012 times)
Han Kyu Chae, Wook Nam, Sung Jin Kim, et al.
Korean J Urol Oncol. 2022;20(1):59-62.

Case Report

Feb 24, 2022
De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy  (2,003 times)
Jee Hwan Yoon, Chang Wook Jeong, Cheol Kwak, et al.
Korean J Urol Oncol. 2022;20(1):34-42.

Original Article

Feb 24, 2022
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up  (1,999 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
J Urol Oncol. 2023;21(1):70-78.

Original Article

Mar 31, 2023
Delaying a Biopsy With Serial Prostate-Specific Antigen Checkup Helps to Identify a Significant Prostate Cancer: A Strategy to Evade Unnecessary Procedures  (1,990 times)
Young Hwii Ko, Byung-Hoon Kim, Wonho Jung, et al.
Korean J Urol Oncol. 2022;20(3):177-185.

Original Article

Aug 25, 2022
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades  (1,966 times)
Sang Heon Han, Hyeong Dong Yuk
J Urol Oncol. 2023;21(1):32-44.

Original Article

Mar 31, 2023

The Landscape of Epidemiology in Urologic Cancers
Peripheral T-Cell Lymphoma of Urinary Bladder Presenting With Just Irritative Voiding Symptoms  (1,953 times)
Byung Hoon Kim
Korean J Urol Oncol. 2022;20(2):133-137.

Case Report

May 26, 2022
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies  (1,885 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
J Urol Oncol. 2023;21(1):23-31.

Reivew Article

Mar 31, 2023
Characteristics of Patients Who Visit Urologic Outpatient Department via Health Promotion Center  (1,837 times)
Jong Cheol Ko, Kwang Suk Lee, Jeong Woo Yoo
Korean J Urol Oncol. 2022;20(3):197-205.

Original Article

Aug 25, 2022
Patient-Specific Tumor Microenvironment Models  (1,792 times)
Jung Woo Lee, Jia Kim, Youngjae Shin, et al.
Korean J Urol Oncol. 2022;20(1):69-69. Corrects: J Urol Oncol 2021;19(4):197

Erratum: Addition of the Co-author

Feb 24, 2022

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI